Listed

Angiodynamics Inc

ANGONasdaqCIK 1275187HealthcareFiscal year ends May 31

Latest reported revenue, Q1 FY2027$80.9mRevenue, Q1 FY2027, three months to 2026-08-31$80.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figureThree months to Aug 31, 2026, from the 10-Q filed Oct 8, 2026.

Latest quarter: Q1 FY2027

Three months to Aug 31, 2026, against the same quarter a year earlier.

  • Revenue$80.9mRevenue, Q1 FY2027, three months to 2026-08-31$80.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure+6.9% on a year earlier
  • Gross margin59.4%Gross margin, Q1 FY2027, three months to 2026-08-31. gross profit / revenueGross profit: $48.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Revenue: $80.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure+4.1 pts on a year earlier
  • Operating margin−9.0%Operating margin, Q1 FY2027, three months to 2026-08-31. operating income / revenueOperating income: −$7.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Revenue: $80.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure+5.1 pts on a year earlier
  • Net margin−8.8%Net margin, Q1 FY2027, three months to 2026-08-31. net income / revenueNet income: −$7.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Revenue: $80.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure+5.6 pts on a year earlier
  • Diluted EPS−$0.17Diluted EPS, Q1 FY2027, three months to 2026-08-31−$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure+34.6% on a year earlier
  • Free cash flow−$15.7mFree cash flow, Q1 FY2027, three months to 2026-08-31. operating cash flow − capital expenditureOperating cash flow: −$15.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Capital expenditure: $379.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure+5.6% on a year earlier

Last eight quarters

Full statements
Revenue$80.9mGross margin 59.4%
Diluted EPS−$0.17, Q1 FY2027
Free cash flow−$15.7m, Q1 FY2027
Angiodynamics Inc, key figures for the last eight quarters
Line itemUnitQ2 FY20252024-11-30Q3 FY20252025-02-28Q4 FY20252025-05-31Q1 FY20262025-08-31Q2 FY20262025-11-30Q3 FY20262026-02-28Q4 FY20262026-05-31Q1 FY20272026-08-31Shape over the periods
Revenue$m72.8Revenue, Q2 FY2025, three months to 2024-11-30$72.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Report this figure72.0Revenue, Q3 FY2025, three months to 2025-02-28$72.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure80.2Revenue, Q4 FY2025, three months to 2025-05-31$80.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure75.7Revenue, Q1 FY2026, three months to 2025-08-31$75.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure79.4Revenue, Q2 FY2026, three months to 2025-11-30$79.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Report this figure78.4Revenue, Q3 FY2026, three months to 2026-02-28$78.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure86.6Revenue, Q4 FY2026, three months to 2026-05-31$86.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure80.9Revenue, Q1 FY2027, three months to 2026-08-31$80.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure
Gross margin%54.8%Gross margin, Q2 FY2025, three months to 2024-11-30. gross profit / revenueGross profit: $39.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Revenue: $72.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Report this figure54.0%Gross margin, Q3 FY2025, three months to 2025-02-28. gross profit / revenueGross profit: $38.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Revenue: $72.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure52.7%Gross margin, Q4 FY2025, three months to 2025-05-31. gross profit / revenueGross profit: $42.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Revenue: $80.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure55.3%Gross margin, Q1 FY2026, three months to 2025-08-31. gross profit / revenueGross profit: $41.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Revenue: $75.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure56.4%Gross margin, Q2 FY2026, three months to 2025-11-30. gross profit / revenueGross profit: $44.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Revenue: $79.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Report this figure52.9%Gross margin, Q3 FY2026, three months to 2026-02-28. gross profit / revenueGross profit: $41.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Revenue: $78.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure54.0%Gross margin, Q4 FY2026, three months to 2026-05-31. gross profit / revenueGross profit: $46.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Revenue: $86.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure59.4%Gross margin, Q1 FY2027, three months to 2026-08-31. gross profit / revenueGross profit: $48.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Revenue: $80.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure
Operating margin%(15.2%)Operating margin, Q2 FY2025, three months to 2024-11-30. operating income / revenueOperating income: −$11.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Revenue: $72.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Report this figure(13.9%)Operating margin, Q3 FY2025, three months to 2025-02-28. operating income / revenueOperating income: −$10.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Revenue: $72.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure(7.2%)Operating margin, Q4 FY2025, three months to 2025-05-31. operating income / revenueOperating income: −$5.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Revenue: $80.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure(14.1%)Operating margin, Q1 FY2026, three months to 2025-08-31. operating income / revenueOperating income: −$10.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Revenue: $75.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure(7.7%)Operating margin, Q2 FY2026, three months to 2025-11-30. operating income / revenueOperating income: −$6.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Revenue: $79.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Report this figure(16.5%)Operating margin, Q3 FY2026, three months to 2026-02-28. operating income / revenueOperating income: −$13.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Revenue: $78.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure(11.8%)Operating margin, Q4 FY2026, three months to 2026-05-31. operating income / revenueOperating income: −$10.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Revenue: $86.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure(9.0%)Operating margin, Q1 FY2027, three months to 2026-08-31. operating income / revenueOperating income: −$7.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Revenue: $80.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure
Net margin%(14.7%)Net margin, Q2 FY2025, three months to 2024-11-30. net income / revenueNet income: −$10.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Revenue: $72.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Report this figure(6.1%)Net margin, Q3 FY2025, three months to 2025-02-28. net income / revenueNet income: −$4.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Revenue: $72.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure(7.5%)Net margin, Q4 FY2025, three months to 2025-05-31. net income / revenueNet income: −$6.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K/A filed 2026-09-29, accession 0001140361-26-037995. Derived: 12-month figure less the 9-month figure.Revenue: $80.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure(14.4%)Net margin, Q1 FY2026, three months to 2025-08-31. net income / revenueNet income: −$10.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Revenue: $75.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure(8.0%)Net margin, Q2 FY2026, three months to 2025-11-30. net income / revenueNet income: −$6.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Revenue: $79.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Report this figure(10.3%)Net margin, Q3 FY2026, three months to 2026-02-28. net income / revenueNet income: −$8.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Revenue: $78.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure(13.2%)Net margin, Q4 FY2026, three months to 2026-05-31. net income / revenueNet income: −$11.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K/A filed 2026-09-29, accession 0001140361-26-037995. Derived: 12-month figure less the 9-month figure.Revenue: $86.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure(8.8%)Net margin, Q1 FY2027, three months to 2026-08-31. net income / revenueNet income: −$7.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Revenue: $80.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure
Diluted EPS$ per share(0.26)Diluted EPS, Q2 FY2025, three months to 2024-11-30−$0.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Report this figure(0.11)Diluted EPS, Q3 FY2025, three months to 2025-02-28−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figurenot reported (Diluted EPS not reported)(0.26)Diluted EPS, Q1 FY2026, three months to 2025-08-31−$0.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure(0.15)Diluted EPS, Q2 FY2026, three months to 2025-11-30−$0.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Report this figure(0.19)Diluted EPS, Q3 FY2026, three months to 2026-02-28−$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figurenot reported (Diluted EPS not reported)(0.17)Diluted EPS, Q1 FY2027, three months to 2026-08-31−$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure
Free cash flow$m1.7Free cash flow, Q2 FY2025, three months to 2024-11-30. operating cash flow − capital expenditureOperating cash flow: $2.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-01-06, accession 0001275187-26-000003. Derived: 6-month figure less the 3-month figure.Capital expenditure: $797.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-01-06, accession 0001275187-26-000003. Derived: 6-month figure less the 3-month figure.Report this figure(15.0)Free cash flow, Q3 FY2025, three months to 2025-02-28. operating cash flow − capital expenditureOperating cash flow: −$13.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-02, accession 0001628280-26-023008. Derived: 9-month figure less the 6-month figure.Capital expenditure: $1.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-02, accession 0001628280-26-023008. Derived: 9-month figure less the 6-month figure.Report this figure18.0Free cash flow, Q4 FY2025, three months to 2025-05-31. operating cash flow − capital expenditureOperating cash flow: $18.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Capital expenditure: $777.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure(16.6)Free cash flow, Q1 FY2026, three months to 2025-08-31. operating cash flow − capital expenditureOperating cash flow: −$15.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Capital expenditure: $731.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure4.2Free cash flow, Q2 FY2026, three months to 2025-11-30. operating cash flow − capital expenditureOperating cash flow: $4.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-01-06, accession 0001275187-26-000003. Derived: 6-month figure less the 3-month figure.Capital expenditure: $422.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-01-06, accession 0001275187-26-000003. Derived: 6-month figure less the 3-month figure.Report this figure(4.1)Free cash flow, Q3 FY2026, three months to 2026-02-28. operating cash flow − capital expenditureOperating cash flow: −$3.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-02, accession 0001628280-26-023008. Derived: 9-month figure less the 6-month figure.Capital expenditure: $1.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-02, accession 0001628280-26-023008. Derived: 9-month figure less the 6-month figure.Report this figure17.0Free cash flow, Q4 FY2026, three months to 2026-05-31. operating cash flow − capital expenditureOperating cash flow: $17.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Capital expenditure: $413.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure(15.7)Free cash flow, Q1 FY2027, three months to 2026-08-31. operating cash flow − capital expenditureOperating cash flow: −$15.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Capital expenditure: $379.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$320.2mGross margin 54.6%
Diluted EPS−$0.88, FY2026
Free cash flow$508.0k, FY2026
Angiodynamics Inc, key figures for the last five fiscal years
Line itemUnitFY20222022-05-31FY20232023-05-31FY20242024-05-31FY20252025-05-31FY20262026-05-31Shape over the periods
Revenue$m316Revenue, FY2022, twelve months to 2022-05-31$316.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-07-25, accession 0001628280-24-032989.Report this figure339Revenue, FY2023, twelve months to 2023-05-31$338.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-07-18, accession 0001275187-25-000014.Report this figure304Revenue, FY2024, twelve months to 2024-05-31$303.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001628280-26-048138.Report this figure292Revenue, FY2025, twelve months to 2025-05-31$292.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001628280-26-048138.Report this figure320Revenue, FY2026, twelve months to 2026-05-31$320.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001628280-26-048138.Report this figure
Gross margin%52.4%Gross margin, FY2022, twelve months to 2022-05-31. gross profit / revenueGross profit: $165.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-07-25, accession 0001628280-24-032989.Revenue: $316.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-07-25, accession 0001628280-24-032989.Report this figure51.4%Gross margin, FY2023, twelve months to 2023-05-31. gross profit / revenueGross profit: $174.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-07-18, accession 0001275187-25-000014.Revenue: $338.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-07-18, accession 0001275187-25-000014.Report this figure50.9%Gross margin, FY2024, twelve months to 2024-05-31. gross profit / revenueGross profit: $154.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-07-14, accession 0001628280-26-048138.Revenue: $303.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001628280-26-048138.Report this figure53.9%Gross margin, FY2025, twelve months to 2025-05-31. gross profit / revenueGross profit: $157.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-07-14, accession 0001628280-26-048138.Revenue: $292.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001628280-26-048138.Report this figure54.6%Gross margin, FY2026, twelve months to 2026-05-31. gross profit / revenueGross profit: $174.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-07-14, accession 0001628280-26-048138.Revenue: $320.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001628280-26-048138.Report this figure
Operating margin%(9.0%)Operating margin, FY2022, twelve months to 2022-05-31. operating income / revenueOperating income: −$28.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-07-25, accession 0001628280-24-032989.Revenue: $316.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-07-25, accession 0001628280-24-032989.Report this figure(15.1%)Operating margin, FY2023, twelve months to 2023-05-31. operating income / revenueOperating income: −$51.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-07-18, accession 0001275187-25-000014.Revenue: $338.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-07-18, accession 0001275187-25-000014.Report this figure(63.3%)Operating margin, FY2024, twelve months to 2024-05-31. operating income / revenueOperating income: −$192.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-07-14, accession 0001628280-26-048138.Revenue: $303.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001628280-26-048138.Report this figure(13.7%)Operating margin, FY2025, twelve months to 2025-05-31. operating income / revenueOperating income: −$40.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-07-14, accession 0001628280-26-048138.Revenue: $292.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001628280-26-048138.Report this figure(12.5%)Operating margin, FY2026, twelve months to 2026-05-31. operating income / revenueOperating income: −$39.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-07-14, accession 0001628280-26-048138.Revenue: $320.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001628280-26-048138.Report this figure
Net margin%(8.4%)Net margin, FY2022, twelve months to 2022-05-31. net income / revenueNet income: −$26.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K/A filed 2026-09-29, accession 0001140361-26-037995.Revenue: $316.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-07-25, accession 0001628280-24-032989.Report this figure(15.5%)Net margin, FY2023, twelve months to 2023-05-31. net income / revenueNet income: −$52.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K/A filed 2026-09-29, accession 0001140361-26-037995.Revenue: $338.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-07-18, accession 0001275187-25-000014.Report this figure(60.7%)Net margin, FY2024, twelve months to 2024-05-31. net income / revenueNet income: −$184.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K/A filed 2026-09-29, accession 0001140361-26-037995.Revenue: $303.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001628280-26-048138.Report this figure(11.6%)Net margin, FY2025, twelve months to 2025-05-31. net income / revenueNet income: −$34.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K/A filed 2026-09-29, accession 0001140361-26-037995.Revenue: $292.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001628280-26-048138.Report this figure(11.5%)Net margin, FY2026, twelve months to 2026-05-31. net income / revenueNet income: −$36.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K/A filed 2026-09-29, accession 0001140361-26-037995.Revenue: $320.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001628280-26-048138.Report this figure
Diluted EPS$ per share(0.68)Diluted EPS, FY2022, twelve months to 2022-05-31−$0.68 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-07-25, accession 0001628280-24-032989.Report this figure(1.33)Diluted EPS, FY2023, twelve months to 2023-05-31−$1.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-07-18, accession 0001275187-25-000014.Report this figure(4.59)Diluted EPS, FY2024, twelve months to 2024-05-31−$4.59 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-07-14, accession 0001628280-26-048138.Report this figure(0.83)Diluted EPS, FY2025, twelve months to 2025-05-31−$0.83 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-07-14, accession 0001628280-26-048138.Report this figure(0.88)Diluted EPS, FY2026, twelve months to 2026-05-31−$0.88 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-07-14, accession 0001628280-26-048138.Report this figure
Free cash flow$m(11.5)Free cash flow, FY2022, twelve months to 2022-05-31. operating cash flow − capital expenditureOperating cash flow: −$7.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-07-25, accession 0001628280-24-032989.Capital expenditure: $4.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-07-25, accession 0001628280-24-032989.Report this figure(3.7)Free cash flow, FY2023, twelve months to 2023-05-31. operating cash flow − capital expenditureOperating cash flow: $78.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-07-18, accession 0001275187-25-000014.Capital expenditure: $3.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-07-18, accession 0001275187-25-000014.Report this figure(30.7)Free cash flow, FY2024, twelve months to 2024-05-31. operating cash flow − capital expenditureOperating cash flow: −$28.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-07-14, accession 0001628280-26-048138.Capital expenditure: $2.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-07-14, accession 0001628280-26-048138.Report this figure(14.6)Free cash flow, FY2025, twelve months to 2025-05-31. operating cash flow − capital expenditureOperating cash flow: −$10.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-07-14, accession 0001628280-26-048138.Capital expenditure: $4.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-07-14, accession 0001628280-26-048138.Report this figure0.5Free cash flow, FY2026, twelve months to 2026-05-31. operating cash flow − capital expenditureOperating cash flow: $3.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-07-14, accession 0001628280-26-048138.Capital expenditure: $2.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-07-14, accession 0001628280-26-048138.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Angiodynamics Inc
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BlackRock, Inc.2026-06-30$49.5m3,803,232Added+117,328
Point72 Asset Management, L.P.2026-06-30$39.8m3,062,517Reduced−119,312
SYSTEMATIC FINANCIAL MANAGEMENT LP2026-06-30$34.3m2,640,214Added+186,513
ARMISTICE CAPITAL, LLC2026-06-30$28.6m2,198,000Added+329,000
ROYCE & ASSOCIATES LP2026-06-30$25.6m1,969,835Added+440,884
Broadfin Holdings LLC2026-06-30$23.7m1,818,533Reduced−250,800
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$22.0m1,694,716Reduced−32,104
WEBER CAPITAL MANAGEMENT LLC /ADV2026-06-30$17.6m1,356,602Reduced−16,547
Nuveen, LLC2026-06-30$15.6m1,199,358Reduced−16,807
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$13.3m1,020,658Added+35,235

Recent filings

All 1,149 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Angiodynamics Inc, recent filings
FiledFormWhat it isAccession number
2026-10-0812:56 ET10-QQuarterly reportPeriod 2026-08-310001628280-26-065423
2026-10-0808:16 ETDEF 14AProxy statementPeriod 2026-11-170001140361-26-039022
2026-10-0807:17 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-26-039020
2026-10-0807:16 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001140361-26-039019
2026-09-2916:01 ET10-K/AAnnual report, amendedPeriod 2026-05-310001140361-26-037995
2026-09-2909:14 ET10-K/AAnnual report, amendedPeriod 2026-05-310001140361-26-037943
2026-07-1415:42 ET10-KAnnual reportPeriod 2026-05-310001628280-26-048138
2026-07-1407:30 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-26-028368
2026-04-2316:59 ET8-K8.01 Other events0001140361-26-016424
2026-04-0213:56 ET10-QQuarterly reportPeriod 2026-02-280001628280-26-023008

Latest annual report

Form 10-K for the fiscal year ended May 31, 2026Filed Jul 14, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Not in this season’s league. The league lists companies whose quarter has ended and whose results are not yet filed.This season’s league

About the filer

CIK
1275187
Tickers
ANGO
Exchange
Nasdaq
SIC code
3841 Surgical & Medical Instruments & Apparatus
Sector
Healthcare
Fiscal year ends
May 31
Incorporated in
DE
Filer category
Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 16:03 ET. Listed shows no prices and gives no investment advice.